-

Sabra Health Care REIT, Inc. Announces Tax Treatment of 2024 Distributions

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid:

Sabra Health Care REIT, Inc.

Common Stock (CUSIP # 78573L106)

Record
Date

 

Payable
Date

Distribution
per Share

 

Total
Ordinary
Dividends

 

Non-Qualified
Dividends

 

Qualified
Dividends

 

Non-Dividend
Distributions

02/13/2024

 

02/29/2024

$

0.3000000

 

 

$

0.2649911

 

 

$

0.2649911

 

$

0.0000000

 

$

0.0350089

 

05/20/2024

 

05/31/2024

 

0.3000000

 

 

 

0.2649911

 

 

 

0.2649911

 

 

0.0000000

 

 

0.0350089

 

08/19/2024

 

08/30/2024

 

0.3000000

 

 

 

0.2649911

 

 

 

0.2649911

 

 

0.0000000

 

 

0.0350089

 

11/15/2024

 

11/29/2024

 

0.3000000

 

 

 

0.2649911

 

 

 

0.2649911

 

 

0.0000000

 

 

0.0350089

 

 

 

$

1.2000000

 

 

$

1.0599644

 

 

$

1.0599644

 

$

0.0000000

 

$

0.1400356

 

 

 

 

100.00%

 

 

88.33%

 

 

 

 

 

11.67%

 

 

 

 

 

 

 

 

 

 

 

The 2024 Non-Qualified Ordinary Dividends are also reported on Form 1099-DIV, Box 5, Section 199A Dividends. Treasury Regulation §1.199A-3(c)(2)(ii) requires that shareholders hold their REIT shares for at least 45 days in order for the dividends to be treated as Section 199A Dividends. Shareholders should consult with their tax advisors to determine whether this requirement affects any portion of the dividends included in Box 5.

Pursuant to Treas. Reg. § 1.1061-6(c), the Company reports that for purposes of section 1061 of the Internal Revenue Code, the One Year Amounts Disclosure and the Three Year Amounts Disclosure are $0.00 with respect to direct and indirect holders of “applicable partnership interests”.

About Sabra

Sabra Health Care REIT, Inc. (Nasdaq:SBRA), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

Contacts

Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com

Sabra Health Care REIT, Inc.

NASDAQ:SBRA

Release Versions

Contacts

Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com

More News From Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) (Nasdaq: SBRA) today released its sixth annual Sustainability Report for fiscal year 2025.The report highlights how Sabra is scaling successful pilot technologies into portfolio-wide initiatives, expanding solutions that improve care delivery and continuing to invest in resilient, efficient operations. Together with the Company's broader sustainability efforts, these initiatives reflect Sabra’s continued int...

Sabra Issues Business Update and Increases Full-Year 2026 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced a business update detailed below. Portfolio Update Sabra has entered into letters of intent to re-tenant all of its 26 properties leased to Avamere (“Avamere”). Under the proposed transition, 22 properties would be transitioned to subsidiaries of Cascadia Healthcare (“Cascadia”), a leading diversified healthcare operator concentrated in the Pacific Northwest with approxi...

Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2026 second quarter earnings release on August 3, 2026, after the close of trading.A conference call with a simultaneous webcast to discuss the 2026 second quarter results will be held on Tuesday, August 4th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID n...
Back to Newsroom